NEW YORK, Nov. 6, 2015 /PRNewswire/ -- The fairness of the
proposed acquisition of MedAssets, Inc. ("MDAS" or the "Company")
by Pamplona Capital Management ("Pamplona") is the subject of an
investigation by WeissLaw LLP, a national class action, shareholder
rights law firm. The investigation is focusing on possible
breaches of fiduciary duty and other violations of law by the Board
of Directors of MDAS for agreeing to sell the Company to Pamplona.
On November 2, 2015, the Company
announced it had reached a definitive agreement for Pamplona to
acquire all outstanding shares of MDAS in a transaction valued at
approximately $2.7 billion, inclusive
of debt. Under the terms of the agreement, MDAS shareholders
will receive $31.35 in cash for each
MDAS share they own.
WeissLaw is investigating whether MDAS's Board acted to maximize
shareholder value prior to entering into the agreement. Notably,
the Company recently announced positive financial results for the
third quarter of 2015. It reported total net revenues of
$190.0 million as compared with
$175.7 million in the same period of
the previous year, representing an increase of $14.3 million year-over-year.
Given these facts, WeissLaw is investigating whether MDAS's
Board acted in the best interests of MDAS's public shareholders by
actively shopping the Company to maximize shareholder value prior
to entering into the agreement with Pamplona. If you own MDAS
shares and would like more information about your rights or our
investigation, or if you have information to share with us, please
contact Joshua Rubin or Kelly Keenan by telephone at (888) 593-4771
or by email at stockinfo@weisslawllp.com.
WeissLaw LLP has litigated hundreds of stockholder class and
derivative actions for violations of corporate and fiduciary
duties. We have recovered over a billion dollars for defrauded
clients and obtained important corporate governance relief in many
of these cases. If you have information or would like legal
advice concerning possible corporate wrongdoing (including insider
trading, waste of corporate assets, accounting fraud, or materially
misleading information), consumer fraud (including false
advertising, defective products, or other deceptive business
practices), or anti-trust violations, please email us at
stockinfo@weisslawllp.com or fill out the form on our
website,
http://www.weisslawllp.com/contact/report_fraud/.
Attorney Advertising. Past results do not guarantee a
similar outcome.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/weisslaw-llp-medassets-inc-acquisition-by-pamplona-capital-management-may-not-be-in-the-best-interest-of-mdas-shareholders-300174230.html
SOURCE WeissLaw LLP